Skip to content

Author

Jian Zhang

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

SGLT-2 inhibitor dapagliflozin improves left ventricular diastolic function and reduces circulating inflammatory markers in HFpEF patients: a retrospective cohort study.

OBJECTIVE This study sought to evaluate the efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitor Dapagliflozin in ameliorating left ventricular diastolic function (LVDF) and attenuating systemic inflammatory biomarkers in patients with heart failure with preserved ejection fraction (HFpEF). METHODS A total o...

Jian-Feng Ye, Jian Zhang, Xu Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.